CNCR vs. HYLD

Last updated Jun 24, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and HYLD (High Yield ETF) are both exchange-traded funds - CNCR is a Health & Biotech Equities fund tracking the Loncar Cancer Immunotherapy Index, while HYLD is a High Yield Bonds fund actively managed by Exchange Traded Concepts. CNCR is passively managed, while HYLD is actively managed. CNCR charges 0.79%/yr vs 1.29%/yr for HYLD.

Performance

CNCR vs. HYLD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and High Yield ETF (HYLD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

HYLD

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. HYLD - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
HYLD High Yield ETF	0.00%

Return for Risk

CNCR vs. HYLD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and High Yield ETF (HYLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Drawdowns

Drawdown Indicators

	CNCR	HYLD	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	—	—
Current Drawdown Current decline from peak	0.00%	—	—
Average Drawdown Average peak-to-trough decline	0.00%	—	—

Volatility

Volatility by Period

	CNCR	HYLD	Difference
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	—	—

CNCR vs. HYLD - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is lower than HYLD's 1.29% expense ratio.

Dividends

CNCR vs. HYLD - Dividend Comparison

Neither CNCR nor HYLD has paid dividends to shareholders.

Position	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
HYLD High Yield ETF	0.00%	4.67%	7.86%	6.45%	7.52%	7.46%	7.97%	7.18%	6.59%	10.87%

Frequently Asked Questions

Which ETF is better, CNCR or HYLD?

On fees, CNCR is cheaper at 0.79% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or HYLD?

CNCR is cheaper with a 0.79% expense ratio, compared with 1.29% for HYLD.

Which ETF pays a higher dividend yield, CNCR or HYLD?

CNCR and HYLD have nearly identical dividend yields, around 0.00%.

What is the main difference between CNCR and HYLD?

CNCR is categorized as Health & Biotech Equities, while HYLD is High Yield Bonds. Their fees differ too: 0.79% for CNCR and 1.29% for HYLD.